Published in eNeuro on March 28, 2017
Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A (1986) 12.92
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Towards a transgenic model of Huntington's disease in a non-human primate. Nature (2008) 4.47
A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med (2013) 4.11
Generation of transgenic non-human primates with germline transmission. Nature (2009) 4.06
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature (2013) 3.55
A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron (2002) 1.97
Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci (2002) 1.66
Toward understanding Machado-Joseph disease. Prog Neurobiol (2011) 1.42
Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus). Stem Cells (2005) 1.35
Trinucleotide repeat instability: a hairpin curve at the crossroads of replication, recombination, and repair. Cytogenet Genome Res (2003) 1.28
Transgenic animal models of neurodegenerative diseases and their application to treatment development. Adv Drug Deliv Rev (2007) 1.24
Common marmoset as a new model animal for neuroscience research and genome editing technology. Dev Growth Differ (2014) 1.23
Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes Cells (2010) 1.19
Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol (2012) 1.09
Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3. Hum Mol Genet (2009) 1.07
Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol (2008) 1.05
Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis. Curr Pharm Des (2008) 0.99
Quantitative measurement of muscle strength in the mouse. J Neurosci Methods (1995) 0.97
Progress and prospects for genetic modification of nonhuman primate models in biomedical research. ILAR J (2013) 0.93
Large genetic animal models of Huntington's Disease. J Huntingtons Dis (2013) 0.92
Germline transmission in transgenic Huntington's disease monkeys. Theriogenology (2015) 0.91
A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci (2014) 0.89
A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats. Neurobiol Dis (2009) 0.89
Monitoring autophagy in muscle diseases. Methods Enzymol (2009) 0.88
Atlas of the developing brain of the marmoset monkey constructed using magnetic resonance histology. Neuroscience (2012) 0.86
Birth of healthy offspring following ICSI in in vitro-matured common marmoset (Callithrix jacchus) oocytes. PLoS One (2014) 0.85
Birth of common marmoset (Callithrix jacchus) offspring derived from in vitro-matured oocytes in chemically defined medium. Theriogenology (2012) 0.85
Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood. PLoS One (2015) 0.85
Ultrasound-guided non-surgical embryo collection in the common marmoset. Reprod Biol (2013) 0.83
Efficient embryo transfer in the common marmoset monkey (Callithrix jacchus) with a reduced transfer volume: a non-surgical approach with cryopreserved late-stage embryos. Biol Reprod (2013) 0.82
Machado-Joseph disease in four Chinese pedigrees: molecular analysis of 15 patients including two juvenile cases and clinical correlations. Neurology (1997) 0.81
Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease. Mov Disord (2014) 0.80
A de novo mutation of the MYH7 gene in a large Chinese family with autosomal dominant myopathy. Hum Genome Var (2015) 0.75
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases. Brain Sci (2017) 0.75